AstraZeneca is Planning a Direct listing on the New York Stock Exchange
Reading Time: 2 minutes
The British-Swedish pharmaceutical company AstraZeneca PLC (LSE: AZN) has announced that it will list its common shares directly on the New York Stock Exchange (NYSE). With this move, the company aims to reach a broader range of investors and increase its visibility in the US market. Until now, AstraZeneca's shares were listed in the form of American Depositary Receipts (ADRs) on Nasdaq, but this structure is set to be replaced. With this step, the company is positioning itself more strongly in the world’s most important capital market for healthcare...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
